← All investors
About
BGF is a growth investor set up in 2011 to address the funding gap for UK and Ireland companies, and is among the most active equity investors in those markets. It takes minority stakes and a patient approach, never a controlling position, and has backed more than 600 businesses. Its portfolio includes the organ-preservation firm OrganOx, sold at a $1.5bn valuation in 2025, and the women's-health company Elvie.
Industries
Stage focus
SeedSeries A
Geography
UKEurope
Notable investments
- OrganOx
- Elvie
- Gaussion
- GoCardless
Raising from BGF?
I've worked with founders across the industrial stack. If BGF is on your list, I can help you map the introduction path, sharpen the narrative, and run a tight process.
Talk to Dan